tradingkey.logo


tradingkey.logo


Kenvue Inc

KVUE
17.570USD
-0.090-0.51%
āļ›āļīāļ” 03/26, 16:00ETāļĢāļēāļ„āļēāļĨāđˆāļēāļŠāđ‰āļē 15 āļ™āļēāļ—āļĩ
33.19BāļĄāļđāļĨāļ„āđˆāļēāļ•āļĨāļēāļ”
22.91P/E TTM


āļĢāļēāļĒāļĨāļ°āđ€āļ­āļĩāļĒāļ”āđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄāļ‚āļ­āļ‡ Kenvue Inc āļšāļĢāļīāļĐāļąāļ—

Kenvue Inc. is a consumer health company. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).

āļ‚āđ‰āļ­āļĄāļđāļĨ Kenvue Inc


āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™KVUE
āļŠāļ·āđˆāļ­āļšāļĢāļīāļĐāļąāļ—Kenvue Inc
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļMay 04, 2023
āļ‹āļĩāļ­āļĩāđ‚āļ­Perry (Kirk L)
āļˆāļģāļ™āļ§āļ™āļžāļ™āļąāļāļ‡āļēāļ™22000
āļ›āļĢāļ°āđ€āļ āļ—āļāļēāļĢāļĢāļąāļāļĐāļēāļ„āļ§āļēāļĄāļ›āļĨāļ­āļ”āļ āļąāļĒOrdinary Share
āļŠāļīāđ‰āļ™āļ›āļĩāļ‡āļšāļ›āļĢāļ°āļĄāļēāļ“May 04
āļ—āļĩāđˆāļ­āļĒāļđāđˆ1 Kenvue Way
āđ€āļĄāļ·āļ­āļ‡SUMMIT
āļ•āļĨāļēāļ”āļŦāļĨāļąāļāļ—āļĢāļąāļžāļĒāđŒNASDAQ OMX NASDAQ Basic NYSE
āļ›āļĢāļ°āđ€āļ—āļĻUnited States of America
āļĢāļŦāļąāļŠāđ„āļ›āļĢāļĐāļ“āļĩāļĒāđŒ07901
āđ‚āļ—āļĢāļĻāļąāļžāļ—āđŒ19088741200
āđ€āļ§āđ‡āļšāđ„āļ‹āļ•āđŒhttps://www.kenvue.com
āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™KVUE
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļMay 04, 2023
āļ‹āļĩāļ­āļĩāđ‚āļ­Perry (Kirk L)

āļœāļđāđ‰āļšāļĢāļīāļŦāļēāļĢāļšāļĢāļīāļĐāļąāļ—āļ‚āļ­āļ‡ Kenvue Inc


āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. Carlton Lawson
Mr. Carlton Lawson
Group President, Europe, Middle East and Africa and Latin America
Group President, Europe, Middle East and Africa and Latin America
111.42K
+12.47%
Ms. Meredith (Meri) Stevens
Ms. Meredith (Meri) Stevens
Chief Operations Officer
Chief Operations Officer
93.62K
+8.09%
Mr. Kirk L. Perry
Mr. Kirk L. Perry
Chief Executive Officer, Director
Chief Executive Officer, Director
62.55K
--
Dr. Caroline Tillett
Dr. Caroline Tillett
Chief Scientific Officer
Chief Scientific Officer
61.45K
+28.19%
Ms. Luani Alvarado
Ms. Luani Alvarado
Chief People Officer
Chief People Officer
61.41K
+7.07%
Mr. Matthew Orlando
Mr. Matthew Orlando
General Counsel
General Counsel
36.83K
+31.45%
Mr. Jan Meurer
Mr. Jan Meurer
Group President, North America
Group President, North America
33.18K
+13.30%
Ms. Charmaine England
Ms. Charmaine England
Chief Growth Officer
Chief Growth Officer
29.06K
+5.38%
Mr. Michael E. Sneed
Mr. Michael E. Sneed
Independent Director
Independent Director
10.79K
-163.64%
Mr. Russell Dyer
Mr. Russell Dyer
Chief Corporate Affairs Officer
Chief Corporate Affairs Officer
4.10K
+58.45%
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. Carlton Lawson
Mr. Carlton Lawson
Group President, Europe, Middle East and Africa and Latin America
Group President, Europe, Middle East and Africa and Latin America
111.42K
+12.47%
Ms. Meredith (Meri) Stevens
Ms. Meredith (Meri) Stevens
Chief Operations Officer
Chief Operations Officer
93.62K
+8.09%
Mr. Kirk L. Perry
Mr. Kirk L. Perry
Chief Executive Officer, Director
Chief Executive Officer, Director
62.55K
--
Dr. Caroline Tillett
Dr. Caroline Tillett
Chief Scientific Officer
Chief Scientific Officer
61.45K
+28.19%
Ms. Luani Alvarado
Ms. Luani Alvarado
Chief People Officer
Chief People Officer
61.41K
+7.07%
Mr. Matthew Orlando
Mr. Matthew Orlando
General Counsel
General Counsel
36.83K
+31.45%

āļŠāļąāļ”āļŠāđˆāļ§āļ™āļ‚āļ­āļ‡āļĢāļēāļĒāđ„āļ”āđ‰

āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 6 āļĄ.āļ„.
āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 6 āļĄ.āļ„.
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Face and Body Care
752.80M
20.00%
Other Self Care
602.24M
16.00%
Pain Care
489.32M
13.00%
Cough, Cold and Allergy
489.32M
13.00%
Other Essential Health
414.04M
11.00%
āļ­āļ·āđˆāļ™ āđ†
1.02B
27.00%
āļ‚āđ‰āļ­āļĄāļđāļĨāļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡āļĒāļąāļ‡āđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļāļēāļĢāđ€āļ›āļīāļ”āđ€āļœāļĒāļˆāļēāļāļ—āļēāļ‡āļšāļĢāļīāļĐāļąāļ—
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆ
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Face and Body Care
752.80M
20.00%
Other Self Care
602.24M
16.00%
Pain Care
489.32M
13.00%
Cough, Cold and Allergy
489.32M
13.00%
Other Essential Health
414.04M
11.00%
āļ­āļ·āđˆāļ™ āđ†
1.02B
27.00%

āļŠāļ–āļīāļ•āļīāļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™

āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļĪāļŦāļąāļŠāļ—āļĩāđˆ 19 āļ.āļž.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļĪāļŦāļąāļŠāļ—āļĩāđˆ 19 āļ.āļž.
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
The Vanguard Group, Inc.
12.21%
State Street Investment Management (US)
6.20%
BlackRock Institutional Trust Company, N.A.
4.98%
Fidelity Management & Research Company LLC
4.09%
MFS Investment Management
3.39%
āļ­āļ·āđˆāļ™ āđ†
69.14%
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
The Vanguard Group, Inc.
12.21%
State Street Investment Management (US)
6.20%
BlackRock Institutional Trust Company, N.A.
4.98%
Fidelity Management & Research Company LLC
4.09%
MFS Investment Management
3.39%
āļ­āļ·āđˆāļ™ āđ†
69.14%
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Investment Advisor
48.93%
Investment Advisor/Hedge Fund
24.43%
Hedge Fund
12.76%
Research Firm
3.08%
Sovereign Wealth Fund
2.44%
Pension Fund
2.02%
Bank and Trust
1.92%
Family Office
0.45%
Family Office
0.19%
āļ­āļ·āđˆāļ™ āđ†
3.77%

āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡āļŠāļ–āļēāļšāļąāļ™


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļĪāļŦāļąāļŠāļ—āļĩāđˆ 1 āļĄ.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļĪāļŦāļąāļŠāļ—āļĩāđˆ 1 āļĄ.āļ„.
āļŠāđˆāļ§āļ‡āđ€āļ§āļĨāļēāļāļēāļĢāļĢāļēāļĒāļ‡āļēāļ™
āļˆāļģāļ™āļ§āļ™āļŠāļ–āļēāļšāļąāļ™
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
2025Q4
2178
1.89B
98.39%
-351.03M
2025Q3
2127
1.94B
100.91%
-295.23M
2025Q2
2098
1.93B
100.46%
-321.30M
2025Q1
2078
1.95B
101.47%
-298.35M
2024Q4
1944
1.96B
102.60%
-253.31M
2024Q3
1828
1.91B
99.61%
-331.64M
2024Q2
1723
1.90B
99.19%
-79.08M
2024Q1
1598
1.90B
99.47%
-51.94M
2023Q4
1442
1.89B
98.66%
-22.82M
2023Q3
1206
1.90B
99.22%
-343.08M
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

āļāļīāļˆāļāļĢāļĢāļĄāļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™


āļŠāļ·āđˆāļ­
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™%
āļ§āļąāļ™āļ—āļĩāđˆ
The Vanguard Group, Inc.
232.47M
12.13%
+85.24K
+0.04%
Sep 30, 2025
State Street Investment Management (US)
114.80M
5.99%
-219.34K
-0.19%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
97.40M
5.08%
+1.60M
+1.67%
Sep 30, 2025
Fidelity Management & Research Company LLC
73.85M
3.85%
-9.05M
-10.92%
Sep 30, 2025
MFS Investment Management
83.59M
4.36%
-4.04M
-4.61%
Sep 30, 2025
Pentwater Capital Management LP
21.08M
1.1%
+20.22M
+2351.16%
Sep 30, 2025
Geode Capital Management, L.L.C.
49.49M
2.58%
+489.37K
+1.00%
Sep 30, 2025
Independent Franchise Partners LLP
30.80M
1.61%
-462.88K
-1.48%
Sep 30, 2025
Norges Bank Investment Management (NBIM)
25.68M
1.34%
+1.26M
+5.15%
Jun 30, 2025
UBS Financial Services, Inc.
22.94M
1.2%
-2.95M
-11.40%
Sep 30, 2025
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

ETF āļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 6 āļ˜.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 6 āļ˜.āļ„.
āļŠāļ·āđˆāļ­
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Renaissance IPO ETF
7.13%
American Century Focused Large Cap Value ETF
3.3%
VanEck Morningstar Wide Moat Value ETF
3.29%
ProShares Ultra Consumer Staples
2.91%
TBG Dividend Focus ETF
2.75%
Brookstone Value Stock ETF
2.2%
Invesco S&P 500 Equal Weight Consumer Staples ETF
2.13%
MarketDesk Focused US Dividend ETF
1.93%
Consumer Staples Select Sector SPDR Fund
1.84%
VanEck Morningstar Wide Moat ETF
1.76%
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
Renaissance IPO ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™7.13%
American Century Focused Large Cap Value ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™3.3%
VanEck Morningstar Wide Moat Value ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™3.29%
ProShares Ultra Consumer Staples
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.91%
TBG Dividend Focus ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.75%
Brookstone Value Stock ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.2%
Invesco S&P 500 Equal Weight Consumer Staples ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.13%
MarketDesk Focused US Dividend ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.93%
Consumer Staples Select Sector SPDR Fund
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.84%
VanEck Morningstar Wide Moat ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.76%

āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ


āļĄāļĩāļāļēāļĢāļˆāđˆāļēāļĒāđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨāđ€āļ›āđ‡āļ™āļˆāļģāļ™āļ§āļ™āļĢāļ§āļĄ 2.32B USD āđƒāļ™āļŠāđˆāļ§āļ‡ 5 āļ›āļĩāļ—āļĩāđˆāļœāđˆāļēāļ™āļĄāļē
āļ§āļąāļ™āļ—āļĩāđˆ
āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ
āļ§āļąāļ™āļ—āļĩāđˆāļšāļąāļ™āļ—āļķāļ
āļ§āļąāļ™āļ—āļĩāđˆāļŠāļģāļĢāļ°āđ€āļ‡āļīāļ™
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
Jan 28, 2026
KVUE.NB Interim Cash Dividend of gross USD 0.2075 paid on Feb 25, 2026 going ex on Feb 11, 2026
Feb 11, 2026
Feb 25, 2026
Feb 11, 2026
Oct 29, 2025
KVUE.NB Final Cash Dividend of gross USD 0.2075 paid on Nov 26, 2025 going ex on Nov 12, 2025
Nov 12, 2025
Nov 26, 2025
Nov 12, 2025
Jul 30, 2025
KVUE.NB Interim Cash Dividend of gross USD 0.2075 paid on Aug 27, 2025 going ex on Aug 13, 2025
Aug 13, 2025
Aug 27, 2025
Aug 13, 2025
Apr 16, 2025
KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on May 28, 2025 going ex on May 14, 2025
May 14, 2025
May 28, 2025
May 14, 2025
Jan 16, 2025
KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on Feb 26, 2025 going ex on Feb 12, 2025
Feb 12, 2025
Feb 26, 2025
Feb 12, 2025
Oct 17, 2024
KVUE.NB Final Cash Dividend of gross USD 0.205 paid on Nov 27, 2024 going ex on Nov 13, 2024
Nov 13, 2024
Nov 27, 2024
Nov 13, 2024
Jul 25, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on Aug 28, 2024 going ex on Aug 14, 2024
Aug 14, 2024
Aug 28, 2024
Aug 14, 2024
Apr 25, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on May 22, 2024 going ex on May 07, 2024
May 08, 2024
May 22, 2024
May 07, 2024
Jan 25, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on Feb 28, 2024 going ex on Feb 13, 2024
Feb 14, 2024
Feb 28, 2024
Feb 13, 2024
Oct 26, 2023
KVUE.NB Final Cash Dividend of gross USD 0.2 paid on Nov 22, 2023 going ex on Nov 07, 2023
Nov 08, 2023
Nov 22, 2023
Nov 07, 2023
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

āļāļēāļĢāđāļšāđˆāļ‡āļŦāļļāđ‰āļ™


āļ§āļąāļ™āļ—āļĩāđˆ
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āļ§āļąāļ™āļ—āļĩāđˆ
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
KeyAI
î™